Skip to content
Free updates Login
SSCRailwayUPSC & State PSC

MTBVAC TB Vaccine: Biofabri-Bharat Biotech Technology Transfer

24 December 20251 min read
SCIENCE & TECHNOLOGYMTBVAC TB Vaccine:Biofabri-BharatBiotech TechnologyTransfer24 December 2025safalsetu.com

Why in the news

Two vaccine makers from Spain and India joined hands to move a next-generation TB vaccine candidate forward.

Key facts

  • Partners: Biofabri (Spain) and Bharat Biotech International (BBIL), Hyderabad.
  • Product: MTBVAC, a live-attenuated candidate.

Exam angle

  • Compared with: BCG, a century-old vaccine.
  • Aimed at broader, longer-lasting cover, including pulmonary TB in adolescents and adults.
  • Agreement type: technology transfer.
  • Spanish partner belongs to the Zendal Group.

Test yourself

1. Which tuberculosis vaccine candidate is covered by the Biofabri-Bharat Biotech agreement?

The notes name MTBVAC as the candidate.

2. Which Indian firm signed the MTBVAC technology transfer pact with Spain's Biofabri?

Hyderabad-based Bharat Biotech International signed the pact.

3. MTBVAC is described as what type of vaccine candidate?

The source calls it a live-attenuated TB vaccine candidate.

This topic is part of Daily Current Affairs 23 & 24 December 2025 (15 topics).

All topics of the dayDay quizDecember 2025

Read more